Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 77 Multiple Myeloma 40 Lymphoma, Large B-Cell, Diffuse 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 37 Lymphoma 37 Lymphoma, Non-Hodgkin 27 Leukemia 26 Leukemia, Lymphocytic, Chronic, B-Cell 18 Burkitt Lymphoma 18 Recurrence 17 Lymphoma, Mantle-Cell 17 Lymphoma, Follicular 17 Neoplasms, Plasma Cell 16 Lymphoma, B-Cell 16 Leukemia, Myeloid, Acute 16 Neuroblastoma 12 Hodgkin Disease 12 Lymphoma, Large-Cell, Immunoblastic 11 Myelodysplastic Syndromes 9 Lymphoma, T-Cell, Peripheral 9 Lymphoma, B-Cell, Marginal Zone 9 Inflammatory Breast Neoplasms 9 Triple Negative Breast Neoplasms 8 Sarcoma 8 Ovarian Neoplasms 8 Immunoblastic Lymphadenopathy 7 Neoplasm Metastasis 6 Melanoma 6 Leukemia, Myeloid, Chronic-Phase 6 Hematologic Neoplasms 6

Interventions

Tablets 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Microbiota × Cyclophosphamide × Clear all

NCT04138979 2019-10-25

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

First Affiliated Hospital of Harbin Medical University

Microbiota

Data powered by HemOnc (CC BY 4.0) Colophon ⚡